BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14581134)

  • 1. Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo.
    Mummert DI; Takashima A; Ellinger L; Mummert ME
    J Dermatol Sci; 2003 Nov; 33(2):91-7. PubMed ID: 14581134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration and maturation of Langerhans cells in skin transplants and explants.
    Larsen CP; Steinman RM; Witmer-Pack M; Hankins DF; Morris PJ; Austyn JM
    J Exp Med; 1990 Nov; 172(5):1483-93. PubMed ID: 2230654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic roles of hyaluronan.
    Mummert ME
    Immunol Res; 2005; 31(3):189-206. PubMed ID: 15888911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New technologies to prevent and treat contact hypersensitivity responses.
    Takashima A; Mummert M; Kitajima T; Matsue H
    Ann N Y Acad Sci; 2000; 919():205-13. PubMed ID: 11083110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
    Price AA; Cumberbatch M; Kimber I; Ager A
    J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
    Mummert ME; Mohamadzadeh M; Mummert DI; Mizumoto N; Takashima A
    J Exp Med; 2000 Sep; 192(6):769-79. PubMed ID: 10993908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
    Jolles S; Christensen J; Holman M; Klaus GB; Ager A
    Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1997 Apr; 289(5):277-84. PubMed ID: 9164638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction by tumour necrosis factor alpha of dose-related changes in Langerhans cell frequency in mice.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1999; 291(7-8):453-8. PubMed ID: 10482017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel protein kinase C and matrix metalloproteinase inhibitors of vegetable origin as potential modulators of Langerhans cell migration following hapten-induced sensitization.
    Staquet MJ; Piccardi N; Piccirilli A; Vincent C; Schmitt D; Msika P
    Int Arch Allergy Immunol; 2004 Apr; 133(4):348-56. PubMed ID: 15031608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-presenting cell function of epidermal cells activated by hapten application.
    Nakano Y
    Br J Dermatol; 1998 May; 138(5):786-94. PubMed ID: 9666823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration of Langerhans cells in an in vitro organ culture system: IL-6 and TNF-alpha are partially responsible for migration into the epidermis.
    Saitoh A; Yasaka N; Osada A; Nakamura K; Furue M; Tamaki K
    J Dermatol Sci; 1999 Apr; 19(3):166-74. PubMed ID: 10215188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation.
    Kobayashi Y; Matsumoto M; Kotani M; Makino T
    J Immunol; 1999 Dec; 163(11):5989-93. PubMed ID: 10570286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses.
    Cumberbatch M; Dearman RJ; Groves RW; Antonopoulos C; Kimber I
    Toxicol Appl Pharmacol; 2002 Jul; 182(2):126-35. PubMed ID: 12140176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adhesion and migration of epidermal dendritic cells].
    Staquet MJ
    Pathol Biol (Paris); 1995 Dec; 43(10):858-62. PubMed ID: 8786890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207.
    Stoitzner P; Holzmann S; McLellan AD; Ivarsson L; Stössel H; Kapp M; Kämmerer U; Douillard P; Kämpgen E; Koch F; Saeland S; Romani N
    J Invest Dermatol; 2003 Feb; 120(2):266-74. PubMed ID: 12542532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous reactivity of murine epidermal Langerhans cells after application of FITC: a histochemical evaluation.
    Doi S; Kobayashi M; Sugiura Y; Sakamoto T; Torii S
    Arch Histol Cytol; 1999 Oct; 62(4):363-73. PubMed ID: 10596947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo.
    Gaiser MR; Lämmermann T; Feng X; Igyarto BZ; Kaplan DH; Tessarollo L; Germain RN; Udey MC
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):E889-97. PubMed ID: 22411813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunopharmacology; 1999 Apr; 41(3):235-43. PubMed ID: 10428652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell migration.
    Cumberbatch M; Dearman RJ; Griffiths CE; Kimber I
    Clin Exp Dermatol; 2000 Jul; 25(5):413-8. PubMed ID: 11012599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.